6h agoWSJ BusinessBULLISH 63M&A
CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion
Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%.
Archived explainer. For the current picture see today's OPCH page.
Why Is OPTION CARE HEALTH I (OPCH) Stock Up Today?
By the Top Tier Newswire AI Desk · October 6, 2026 at 9:33 AM ET · reviewed against 23 wire stories
OPTION CARE HEALTH I (OPCH) is up +32.84% in the latest session. Our newswire has captured 23 stories on OPCH across 14 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Option Care Health (OPCH) surged 32.84% to $31.05 in early trading on October 6, driven by a definitive agreement to be acquired by a consortium led by private equity firm Clayton, Dubilier & Rice (CD&R) and McKesson. The deal values the company at $32.05 per share, or $5.8 billion in enterprise value, with CD&R taking a 51% stake and McKesson a 49% stake. The announcement triggered a significant gap up from the prior close of $23.37, with the stock reaching a session high of $31.30.
What Happened
Option Care Health filed an 8-K with the SEC on October 6, disclosing the material definitive agreement. The company also withdrew previously disclosed guidance, likely in anticipation of the transaction. The deal price of $32.05 per share represents a premium over the stock’s recent price, which had closed at $23.37 the previous session. The acquisition is expected to provide a clear exit for shareholders and consolidate the at-home infusion therapy market under the combined ownership of CD&R and McKesson.
What The Data Shows
The stock opened at $28.16, a 20.5% gap up, and traded in a volatile range before settling at $31.05. Volume reached 14.8 million shares, more than six times the 3-month average. The price has risen 1.9% over the past eight sessions, closing at $23.37 before the announcement. The stock hit a fresh 52-week high on October 6. With a market cap of $3.4 billion and a P/E ratio of 17.7, the deal price of $32.05 implies a significant valuation premium.
What To Watch
The transaction is expected to close in October 2026, as outlined in the agreement. Investors should monitor for further regulatory filings and updates on the timeline. Coverage has expanded rapidly, with 23 stories from 14 sources in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
OPCH by the numbers
Last: $31.05Session: +32.84%7 sessions: +1.87%Coverage: 23 stories / 14 sourcesAI sentiment: 62/100 (bullish)Mkt cap: $3.4BP/E: 17.752w: $18.01 to $36.80
The headlines behind the move
6h agoTipRanksBULLISH 58M&A
Option Care Health to Be Taken Private in Buyout
Option Care Health ( ($OPCH) ) has issued an update. On October 5, 2026, Option Care Health agreed to be acquired by an investor group led by Clayton, Dubilier &</p...
6h agoSeeking AlphaBULLISH 78M&A
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover
Option Care Health (OPCH) shares surged 34% after CD&R and McKesson (MCK) agreed to buy it for $32.05/share ($5.8B incl. debt).
6h agoThe FlyBEARISH 34General
Option Care Health withdraws previously disclosed guidance
6h agoSEC 8-KNEUTRAL 50General
Option Care Health, Inc. (OPCH) files 8-K
Filed: 2026-10-06 AccNo: 0001104659-26-113904 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
7h agoThe FlyBULLISH 63M&A
McKesson, CD&R to acquire Option Care Health for $32.05 per share
7h agoMarketChameleonBULLISH 63M&A
CD&R and McKesson Agree to Buy Option Care Health for $32.05 a Share, With McKesson Taking a 49% Stake
CD&R and McKesson signed a definitive agreement to acquire Option Care Health for $32.05 per share, valuing the transaction at about $5.8 billion in enterprise value. The deal would leave CD&R with roughly 51% ownership and McKesson with about 49%, with OPCH expected to become privately held after closing in the first half of 2027 pending stockholder and regulatory approvals.
7h agoBloombergBULLISH 63M&A
McKesson, CD&R to Buy Option Care in $5.8 Billion Deal
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on OPCH: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier OPCH move explainers: 2026-10-06